Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group. Grangeon L, et al. Among authors: laplanche jl. J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111. J Alzheimers Dis. 2016. PMID: 26890785
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases].
Magnin E, Dumurgier J, Bouaziz-Amar E, Bombois S, Wallon D, Gabelle A, Lehmann S, Blanc F, Bousiges O, Hannequin D, Jung B, Miguet-Alfonsi C, Quillard M, Pasquier F, Peoc'h K, Laplanche JL, Hugon J, Paquet C; pour le groupe ePLM (étude des biomarqueurs de la Ponction Lombaire Multicentrique). Magnin E, et al. Among authors: laplanche jl. Rev Med Interne. 2017 Apr;38(4):250-255. doi: 10.1016/j.revmed.2016.10.383. Epub 2016 Nov 24. Rev Med Interne. 2017. PMID: 27890382 Review. French.
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting.
Dumurgier J, Vercruysse O, Paquet C, Bombois S, Chaulet C, Laplanche JL, Peoc'h K, Schraen S, Pasquier F, Touchon J, Hugon J, Lehmann S, Gabelle A. Dumurgier J, et al. Among authors: laplanche jl. Alzheimers Dement. 2013 Jul;9(4):406-13. doi: 10.1016/j.jalz.2012.06.006. Epub 2012 Nov 8. Alzheimers Dement. 2013. PMID: 23141384 Clinical Trial.
Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease.
Dumurgier J, Mouton-Liger F, Lapalus P, Prevot M, Laplanche JL, Hugon J, Paquet C; Groupe d’Investigation du Liquide Cephalorachidien (GIL) Study Network. Dumurgier J, et al. Among authors: laplanche jl. PLoS One. 2013;8(1):e53587. doi: 10.1371/journal.pone.0053587. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23320095 Free PMC article.
Exacerbated CSF abnormalities in younger patients with Alzheimer's disease.
Dumurgier J, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc'h K, Schraen S, Sablonnière B, Pasquier F, Touchon J, Lehmann S, Hugon J, Paquet C. Dumurgier J, et al. Among authors: laplanche jl. Neurobiol Dis. 2013 Jun;54:486-91. doi: 10.1016/j.nbd.2013.01.023. Epub 2013 Feb 13. Neurobiol Dis. 2013. PMID: 23416172
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.
Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc'h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A. Lehmann S, et al. Among authors: laplanche jl. Alzheimers Dement. 2014 Oct;10(5 Suppl):S390-S394.e2. doi: 10.1016/j.jalz.2013.06.008. Epub 2013 Oct 23. Alzheimers Dement. 2014. PMID: 24269268
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.
Lehmann S, Dumurgier J, Schraen S, Wallon D, Blanc F, Magnin E, Bombois S, Bousiges O, Campion D, Cretin B, Delaby C, Hannequin D, Jung B, Hugon J, Laplanche JL, Miguet-Alfonsi C, Peoc'h K, Philippi N, Quillard-Muraine M, Sablonnière B, Touchon J, Vercruysse O, Paquet C, Pasquier F, Gabelle A. Lehmann S, et al. Among authors: laplanche jl. Alzheimers Res Ther. 2014 Jun 26;6(3):38. doi: 10.1186/alzrt267. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478015 Free PMC article.
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.
Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc'h K, Sablonnière B, Kastanenka KV, Delaby C, Pasquier F, Touchon J, Hugon J, Paquet C, Lehmann S. Dumurgier J, et al. Among authors: laplanche jl. Alzheimers Res Ther. 2015 Jun 1;7(1):30. doi: 10.1186/s13195-015-0114-5. eCollection 2015. Alzheimers Res Ther. 2015. PMID: 26034513 Free PMC article.
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers.
Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc H K, Laplanche JL, Bouaziz-Amar E, Hannequin D, Sablonniere B, Buee L, Hugon J, Schraen S, Pasquier F, Bombois S, For The E-Plm Group. Vercruysse O, et al. Among authors: laplanche jl. Curr Alzheimer Res. 2018;15(7):691-700. doi: 10.2174/1567205015666180110113238. Curr Alzheimer Res. 2018. PMID: 29318973
221 results